Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.0329 per EA under NDC 62559019505. Its NADAC has been published 60 times since May 7, 2025.
Strength
.5 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559019505
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077396On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 60 times since May 7, 2025, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0329 per EA |
|---|---|
| All-time high | $0.0443 (Jun 11, 2025) |
| All-time low | $0.0329 (Jun 17, 2026) |
| 52-week high | $0.0439 |
| 52-week low | $0.0329 |
| Median price | $0.0422 |
| Average price | $0.0397 |
| Largest weekly change | -9.4% (Jan 21, 2026) |
| Weeks tracked | 60 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.0329 per EA (NDC 62559019505), effective Jun 24, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has declined 25.0%. It has been tracked across 60 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since May 7, 2025, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0329 (Jun 17, 2026) to a high of $0.0443 (Jun 11, 2025), with a median of $0.0422 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LORAZEPAM 0.5 MG TABLET, is $0.0203 per EA — about 38% below LORAZEPAM 0.5 MG TABLET.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 62559019505) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification